Fundraising FoxBioskryb
3 known investors
Find your way into Bioskryb
Sign up to see every warm intro you have to Bioskryb
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioskryb team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bioskryb provides genomic sequencing and single-cell analysis solutions for biopharmaceutical companies and clinical researchers, enabling them to characterize circulating tumor cells, identify biomarkers, and support drug development across oncology, neurology, and cell/gene editing applications.
Founders & leadership
CG
Chuck GawadChief Scientific Officer / Co-Founder
Investors · 3
Also in the syndicate · 1
Wilson Sonsini Goodrich & Rosati
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundJan 2020
Anzu Partners (lead), Wilson Sonsini Goodrich & Rosati
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Bioskryb do?
- Bioskryb provides genomic sequencing and single-cell analysis solutions for biopharmaceutical companies and clinical researchers, enabling them to characterize circulating tumor cells, identify biomarkers, and support drug development across oncology, neurology, and cell/gene editing applications.
- Who founded Bioskryb?
- Bioskryb was founded by Chuck Gawad.
- Who are Bioskryb's investors?
- Bioskryb's investors include Anzu Partners, Seed Healthcare.